Please login to the form below

Not currently logged in
Email:
Password:

Roche launches RPF

Swiss pharmaceutical company, Roche, has launched a new international research grant scheme for scientists involved in collaborative projects between the industry and academic institutions
Swiss pharmaceutical company, Roche, has launched a new international research grant scheme for scientists involved in collaborative projects between the industry and academic institutions.

The scheme will replace the current Roche Research Foundation (RRF), which will cease operating by the end of 2008. It is hoped that the new autonomous foundation will promote young talent and research excellence in Switzerland.

Scientists who are awarded a grant under the recently launched Roche Postdoc Fellowship (RPF) programme will benefit from scientific mentoring from the company and its academic partners. The company aims to award 100 postdoctoral fellowships in various areas of therapeutic research over the next two years, with a long-term view of expanding the RPF into an international scheme.

ìWe believe firmly that in setting up this programme we are making an important contribution to scientific excellence at international level," said Dr Renè Imhof, designated head of the RPF programme.

"Our intention is to channel the positive momentum generated by the RRF into the new, much broader Roche Postdoc Fellowship programme and continue its success there."

Roche plans to unveil an internet site for the scheme during the 4th quarter of 2008 that will include further information about the RPF and an online application system.

20th June 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hamell - Cake

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics